Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 87

1.

Impact of cardiometabolic risk factors on major cardiovascular events in patients with familial combined hyperlipidemia.

Skoumas I, Masoura C, Aznaouridis K, Metaxa V, Tsokanis A, Papadimitriou L, Tousoulis D, Pitsavos C, Stefanadis C.

Circ J. 2013;77(1):163-8. Epub 2012 Sep 28.

2.

Evidence that non-lipid cardiovascular risk factors are associated with high prevalence of coronary artery disease in patients with heterozygous familial hypercholesterolemia or familial combined hyperlipidemia.

Skoumas I, Masoura C, Pitsavos C, Tousoulis D, Papadimitriou L, Aznaouridis K, Chrysohoou C, Giotsas N, Toutouza M, Tentolouris C, Antoniades C, Stefanadis C.

Int J Cardiol. 2007 Oct 1;121(2):178-83. Epub 2006 Dec 22.

PMID:
17188767
3.

Nomogram to diagnose familial combined hyperlipidemia on the basis of results of a 5-year follow-up study.

Veerkamp MJ, de Graaf J, Hendriks JC, Demacker PN, Stalenhoef AF.

Circulation. 2004 Jun 22;109(24):2980-5. Epub 2004 Jun 7.

4.

Prevalence and determinants of coronary artery disease in males and females with familial combined hyperlipidaemia.

Pitsavos C, Skoumas I, Masoura C, Aznaouridis K, Papadimitriou L, Chrysohoou C, Giotsas N, Toutouza M, Stefanadis C.

Atherosclerosis. 2008 Aug;199(2):402-7. doi: 10.1016/j.atherosclerosis.2007.11.021. Epub 2007 Dec 27.

PMID:
18164018
5.

[Familial combined hyperlipidemia, metabolic syndrome and cardiovascular disease].

Martinez-Hervás S, Real JT, Priego A, Sanz J, Martín JM, Carmena R, Ascaso JF.

Rev Esp Cardiol. 2006 Nov;59(11):1195-8. Spanish.

6.

Lipoprotein (a) concentrations in patients with familial combined hyperlipidemia and hypertension.

Netea RT, Netea MG, Bredie SJ, Demacker PN, Hancu N, Thien T, Stalenhoef AF.

Neth J Med. 1999 Jul;55(1):39-45.

PMID:
10431554
7.

Carotid atherosclerosis and lipoprotein particle subclasses in familial hypercholesterolaemia and familial combined hyperlipidaemia.

Jarauta E, Mateo-Gallego R, Gilabert R, Plana N, Junyent M, de Groot E, Cenarro A, Masana L, Ros E, Civeira F.

Nutr Metab Cardiovasc Dis. 2012 Jul;22(7):591-7. doi: 10.1016/j.numecd.2010.10.011. Epub 2010 Dec 31.

PMID:
21196102
8.

High plasma level of remnant-like particles cholesterol in familial combined hyperlipidemia.

de Graaf J, van der Vleuten GM, ter Avest E, Dallinga-Thie GM, Stalenhoef AF.

J Clin Endocrinol Metab. 2007 Apr;92(4):1269-75. Epub 2007 Jan 16.

PMID:
17227806
9.

Metabolic syndrome: A predictor of adverse outcomes after carotid revascularization.

Protack CD, Bakken AM, Xu J, Saad WA, Lumsden AB, Davies MG.

J Vasc Surg. 2009 May;49(5):1172-80.e1; discussion 1180. doi: 10.1016/j.jvs.2008.12.011.

10.

Contribution of the hepatic lipase gene to the atherogenic lipoprotein phenotype in familial combined hyperlipidemia.

Allayee H, Dominguez KM, Aouizerat BE, Krauss RM, Rotter JI, Lu J, Cantor RM, de Bruin TW, Lusis AJ.

J Lipid Res. 2000 Feb;41(2):245-52.

11.

Segregation analysis of plasma apolipoprotein B levels in familial combined hyperlipidemia.

Bredie SJ, van Drongelen J, Kiemeney LA, Demacker PN, Beaty TH, Stalenhoef AF.

Arterioscler Thromb Vasc Biol. 1997 May;17(5):834-40.

12.

A tertiary care hospital-based study of conventional risk factors including lipid profile in proven coronary artery disease.

Goel PK, Bharti BB, Pandey CM, Singh U, Tewari S, Kapoor A, Garg N, Sinha N.

Indian Heart J. 2003 May-Jun;55(3):234-40.

PMID:
14560932
13.

The Gln223Arg polymorphism in the leptin receptor is associated with familial combined hyperlipidemia.

van der Vleuten GM, Kluijtmans LA, Hijmans A, Blom HJ, Stalenhoef AF, de Graaf J.

Int J Obes (Lond). 2006 Jun;30(6):892-8.

PMID:
16432543
14.

Lower high-density lipoprotein cholesterol is a significant and independent risk for coronary artery disease in Japanese men.

Satoh H, Tomita K, Fujii S, Kishi R, Tsutsui H.

J Atheroscler Thromb. 2009;16(6):792-8. Epub 2009 Dec 22.

15.

Pulse wave velocity in familial combined hyperlipidemia.

ter Avest E, Holewijn S, Bredie SJ, van Tits LJ, Stalenhoef AF, de Graaf J.

Am J Hypertens. 2007 Mar;20(3):263-9.

PMID:
17324737
16.

Lipid measures for prediction of incident cardiovascular disease in diabetic and non-diabetic adults: results of the 8.6 years follow-up of a population based cohort study.

Tohidi M, Hatami M, Hadaegh F, Safarkhani M, Harati H, Azizi F.

Lipids Health Dis. 2010 Jan 23;9:6. doi: 10.1186/1476-511X-9-6.

17.

Lipoprotein-associated phospholipase A(2) bound on high-density lipoprotein is associated with lower risk for cardiac death in stable coronary artery disease patients: a 3-year follow-up.

Rallidis LS, Tellis CC, Lekakis J, Rizos I, Varounis C, Charalampopoulos A, Zolindaki M, Dagres N, Anastasiou-Nana M, Tselepis AD.

J Am Coll Cardiol. 2012 Nov 13;60(20):2053-60. doi: 10.1016/j.jacc.2012.06.057. Epub 2012 Oct 17.

18.

Aldosterone, mortality, and acute ischaemic events in coronary artery disease patients outside the setting of acute myocardial infarction or heart failure.

Ivanes F, Susen S, Mouquet F, Pigny P, Cuilleret F, Sautière K, Collet JP, Beygui F, Hennache B, Ennezat PV, Juthier F, Richard F, Dallongeville J, Hillaert MA, Doevendans PA, Jude B, Bertrand M, Montalescot G, Van Belle E.

Eur Heart J. 2012 Jan;33(2):191-202. doi: 10.1093/eurheartj/ehr176. Epub 2011 Jun 30.

PMID:
21719456
19.

Impact of metabolic syndrome on future cardiovascular events in patients with first acute myocardial infarction.

Selcuk H, Temizhan A, Selcuk MT, Sen T, Maden O, Tekeli S, Sasmaz A.

Coron Artery Dis. 2009 Sep;20(6):370-5. doi: 10.1097/MCA.0b013e32832ed31e.

PMID:
19609207
20.

Supplemental Content

Support Center